REFRACTORY SOLID TUMOR MALIGNANCIES

Clinical trials for REFRACTORY SOLID TUMOR MALIGNANCIES explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY SOLID TUMOR MALIGNANCIES trials appear

Sign up with your email to follow new studies for REFRACTORY SOLID TUMOR MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Engineered immune cells take aim at stubborn solid tumors

Disease control Not yet recruiting

This trial tests a new approach for people with solid tumors that have returned or not responded to standard treatments. The therapy uses the patient's own myeloid cells, a type of immune cell, which are genetically modified in a lab to produce a cancer-fighting protein called IL…

Matched conditions: REFRACTORY SOLID TUMOR MALIGNANCIES

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jul 02, 2026 04:00 UTC

REFRACTORY SOLID TUMOR MALIGNANCIES

Get alerted when new REFRACTORY SOLID TUMOR MALIGNANCIES trials appear

Engineered immune cells take aim at stubborn solid tumors